TELOMEREX Trademark

Trademark Overview


On Monday, April 15, 2024, a trademark application was filed for TELOMEREX with the United States Patent and Trademark Office. The USPTO has given the TELOMEREX trademark a serial number of 98499583. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, November 4, 2024. This trademark is owned by Rejuvenation Technologies Inc.. The TELOMEREX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Nutraceuticals for the treatment of or prevention of diseases and conditions related to short telomeres; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions related to short telomeres

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating or preventing diseases and conditions related to short telomeres

Pharmaceutical drug development services; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer

General Information


Serial Number98499583
Word MarkTELOMEREX
Filing DateMonday, April 15, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, November 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements


Goods and ServicesNutraceuticals for the treatment of or prevention of diseases and conditions related to short telomeres; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions related to short telomeres
Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals for treating or preventing diseases and conditions related to short telomeres
Goods and ServicesPharmaceutical drug development services; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, April 15, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 15, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRejuvenation Technologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events


Event DateEvent Description
Monday, April 15, 2024NEW APPLICATION ENTERED
Thursday, September 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 28, 2024ASSIGNED TO EXAMINER
Tuesday, October 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED